Clarithromycin regimens for pulmonary Mycobacterium avium complex: The first 50 patients

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 6 I, 1996, Pages 1766-1772

  Wallace Jr , Richard James ^a   Brown, Barbara Ann ^b   Griffith, David Eugene ^b   Girard, William Meshew ^b   Murphy, David Thompson ^b  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; BACTERIUM ISOLATION; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MYALGIA; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL; UVEITIS; VISUAL IMPAIRMENT;

EID: 0029888154     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.6.8665032     Document Type: Article

References (33)

1. Ahn, C. H., S. S. Ahn, R. A. Anderson, D. T. Murphy, and A. Mammo. 1986. A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex. Am. Rev. Respir. Dis. 134:438-441.
2. Wallace, R. J., Jr., B. A. Brown, D. E. Griffith, W. M. Girard, D. T. Murphy, G. O. Onyi, V. A. Steingrube, and G. H. Mazurek. 1994. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am. J. Respir. Crit. Care Med. 149: 1335-1341.
3. Dautzenberg, B., C. Truffot, S. Legris, M.-C. Meyohas, H. C. Berlie, A. Mercat, S. Chevret, and J. Grosset. 1991. Activity of clarithromycin against Mycobacterium avium infection in patients with AIDS: a controlled clinical trial. Am. Rev. Respir. Dis. 144:564-569.
4. Young, L. S., W. Wiviott, M. Wu, P. Kolonoski, R. Bolan, and C. B. Inderlied. 1991. Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet 338: 1107-1109.
5. Dautzenberg, B., T. S. Marc, M. C. Meyohas, M. Eliaszewitch, F. Haniez, A. M. Rogues, S. De Wit, L. Cotte, J. P. Chauvin, and J. Grosset. 1993. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Arch. Intern. Med. 153: 368-372.
6. Chaisson, R. E., C. A. Benson, M. P. Dube, L. B. Heifets, J. A. Korvick, S. Elkin, T. Smith, J. C. Craft, F. R. Sattler, and the AIDS Clinical Trials Group Protocol 157 Study Team. 1994. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. Ann. Intern. Med. 121:905-911.
7. DeLalla, F., R. Maserati, P. Scarpellini, P. Marone, R. Nicolin, F. Caccamo, and R. Rigoli. 1992. Clarithromycin-Ciprofloxacin-Amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. Antimicrob. Agents Chemother. 36:1567-1569.
8. Nightingale, S. D., D. W. Cameron, F. M. Gordin, P. M. Sullam, D. L. Ohn, R. E. Chaisson, L. J. Eron, P. D. Sparti, B. Bihari, D. L. Kaufman, J. J. Stern, D. D. Pearce, W. G. Weinberg, A. LaMarca, and F. P. Siegal. 1993. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N. Engl. J. Med. 16:828-833.
9. Sullam, P. M., F. M. Gordin, B. A. Wynne, and the Rifabutin Treatment Group. 1994. Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. Clin. Infect. Dis. 19:84-86.
10. Wallace, R. J., Jr., B. A. Brown, and D. E. Griffith. 1993. Drug intolerance to high dose clarithromycin among elderly patients. Diagn. Microbiol. Infect. Dis. 16:215-221.
11. Griffith, D. E., R. J. Wallace, Jr., B. A. Brown, W. M. Girard, D. T. Murphy, and G. O. Onyi. 1995. Azithromycin monotherapy for HIV (-) patients with Mycobacterium avium intracellulare complex lung disease. Abstract presented at the International Conference of American Thoracic Society (abstract). Am. J. Respir. Crit. Care Med. 151:A477.
12. Griffith, D. E., B. A. Brown, W. M. Girard, and R. J. Wallace, Jr. 1995. Adverse events associated with high dose rifabutin in macrolide-containing regimens for Mycobacterium avium intracellulare lung disease. Abstract presented at the International Conference of American Thoracic Society (abstract). Am. J. Respir. Crit. Care Med. 151: A477.
13. Wallace, R. J., Jr., R. O'Brien, J. Glassroth, J. Raleigh, and A. Dutt. 1990. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am. Rev. Respir. Dis. 142:940-953.
14. Roberts, G. D., E. W. Koneman, and Y. K. Kim. 1990. Mycobacterium. In A. Balows, editor. Manual of Clinical Microbiology, 5th ed. American Society for Microbiology, Washington, DC. 304-339.
15. Whittier, S., R. L. Hopfer, M. R. Knowles, and P. H. Gilligan. 1993. Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. J. Clin. Microbiol. 31:861-864.
16. Brown, B. A., R. J. Wallace, Jr., and G. O. Onyi. 1992. Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system. Antimicrob. Agents Chemother. 36:1987-1990.
17. Wallace, R. J., Jr., D. R. Nash, L. C. Steele, and V. Steingrube. 1986. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J. Clin. Microbiol. 24:976-981.
18. Fernandes, P. B., N. Ramer, R. O. Rode, and L. Freiberg. 1988. Bioassay for A-56268 (TE-031) and identification of its major metabolite, 14-hydroxy-6-0-methyl erythromycin. J. Clin. Microbiol. Infect. Dis. 7:73-76.
19. Meier, A., P. Kirschner, B. Springer, V. A. Steingrube, B. A. Brown, R. J. Wallace, Jr., and E. C. Böttger. 1994. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob. Agents Chemother. 38:381-384.
20. Wallace, R. J., Jr., B. A. Brown, D. E. Griffith, W. Girard, and K. Tanaka. 1995. Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection. J. Infect. Dis. 171:747-750.
21. Brown, B. A., R. J. Wallace, Jr., D. E. Griffith, and W. Girard. 1995. Clarithromycin-induced hepatotoxicity. Clin. Infect. Dis. 20:1073-1074.
22. Dautzenberg, B., D. Piperno, P. Diot, C. Truffot-Pernot, J. P. Chauvin, and the Clarithromycin Study Group of France. 1995. Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Chest 107:1035-1040.
23. Abrams, D. I., T. F. Mitchell, C. C. Child, S. C. Shiboski, C. L. Brosgart, M. M. Mass, and the Community Consortium. 1993. Clofazimine as prophylaxis for disseminated Mycobacterium avium complex infection in AIDS. J. Infect. Dis. 167:1459-1463.
24. Kemper, C. A., D. Havlir, D. Highighat, M. Dubé, A. E. Bartok, J. P. Sison, Y. Yao, B. Yangco, J. M. Leedom, J. G. Tilles, J. A. McCutchan, and S. C. Deresinski. 1994. The individual microbiologic effect on three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS. J. Infect. Dis. 170:157-164.
25. Gangadharam, P. R. J., V. K. Perumal, B. T. Jairam, P. N. Rao, A. K. Nguyen, D. C. Farhi, and M. D. Iseman. 1987. Activity of rifabutin alone or in combination with clofazimine or ethambutol or both against acute and chronic experimental Mycobacterium intracellulare infections. Am. Rev. Respir. Dis. 136:329-333.
26. Rastogi, N., and V. Labrousse. 1991. Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex. Antimicrob. Agents Chemother. 35:462-470.
27. Hardy, D. J., D. R. P. Guay, and R. N. Jones. 1992. Clarithromycin, a unique macrolide: a pharmacokinetic, microbiological, and clinical overview. Diagn. Microbiol. Infect. Dis. 15:39-53.
28. Goldberger, M., and H. Masur. 1994. Clarithromycin therapy for Mycobacterium avium complex disease in patients with AIDS: Potential and problems. Ann. Intern. Med. 121:974-976.
29. Shafran, S. D., J. Deschenes, M. Miller, P. Phillips, and E. Toma. 1994. Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. N. Engl. J. Med. 330:438-439.
30. The Datri 001 Study Group. Albany Medical College, Albany, NY, University of Maryland, Baltimore, MD, Westat, Inc., Rockville, MD, and the Division of AIDS, NIAID, Bethesda, MD. 1994. Abstract A2: Co-adminslration of clarithromycin alters the concentration-time profile of rifabutin. Abstract of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Orlando, FL.
31. Gangadharam, P. R. J., V. K. Perumal, N. R. Podapati, L. Kesavalu, and M. D. Iseman. 1988. In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice. Antimicrob. Agents Chemother. 32:1400-1403.
32. Chiu, J., J. Nussbaum, S. Bozzette, J. G. Tilles, L. S. Young, J. Leedom, P. N. R. Heseltine, J. A. McCutchan, and the California Collarborative Treatment Group. 1990. Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. Ann. Intern. Med. 113:358-361.
33. Lounis, N., B. Ji, C. Truffot-Pernot, and J. Grosser 1995. Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model. Antimicrob. Agents Chemother. 39:608-612.